🟢 Haemonetics is trading 4.4% up today after BofA raised its price target to $100

Haemonetics is trading 4.4% higher at $91.06 after BofA Securities raised its price target to $100 from $93 on August 12, 2026; the source does not explicitly confirm causation.

• Broader markets are modestly firmer following in-line July CPI, supporting risk appetite.
• A recent earnings beat and raised fiscal 2027 outlook remain supportive background factors.